LOCKUP AGREEMENTLockup Agreement • October 19th, 2023 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances) • Delaware
This Lockup Agreement is dated as of [·], 2023 and is between (i) Graf Acquisition Corp. IV, a Delaware corporation (“Acquiror”), (ii) each holder of 5% or more of the shares of Fully Diluted Company Common Stock as of the date of the Merger Agreement (as defined below) each Company Management Holder that holds Equity Securities (as defined below) of the Company set forth in Exhibit A hereto and (iii) the other Persons who enter into a joinder to this Agreement substantially in the form of Exhibit B hereto with Acquiror in order to become a “Stockholder Party” for purposes of this Agreement (the foregoing Persons other than Acquiror collectively, the “Stockholder Parties”). Capitalized terms used but not defined herein shall have the meanings assigned to them in the Merger Agreement (as defined below).
SUPPORT AGREEMENTSupport Agreement • October 19th, 2023 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances)
This Support Agreement (this “Agreement”), dated as of April 14, 2023, is entered into by and among Graf Acquisition Corp. IV, a Delaware corporation (“Acquiror”), NKGen Biotech, Inc., a Delaware corporation (the “Company”) and certain of the stockholders of the Company, whose names appear on the signature pages of this Agreement (such stockholders, each, a “Stockholder” and together, the “Stockholders”).
